Servier SA, France's largest private pharmaceutical company, has made a HUF 28,000 ($125.8) per share offer for the 49% of Hungarian generics maker Egis Pharmaceuticals PLC it does not already own. The buyout, worth 107 billion forints ($482.8 million), was announced on Sept. 24.
Servier’s move seems well-timed. Sales at the Budapest-based group are in decline - mainly because of regulatory changes in its...